Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC αvβ1 integrin-IN-1 TFA | 1689540-62-2 | MFCD30747846 | 98.3% | 672.67 g·mol⁻¹ | C28H35F3N6O8S | 10 MG
SDP

Catalog No. 5000215007
Encompass_Preferred

αvβ1 integrin-IN-1 TFA (Compound C8) is a potent, selective small-molecule inhibitor of αvβ1 integrin for research use. It has an IC50 of 0.63 nM and demonstrates antifibrotic effects in mouse models of liver and lung fibrosis. Supplied as a white to off-white solid and as DMSO solutions, it is provided with high purity for biochemical and cellular assays.

  • Potent αvβ1 inhibition with IC50 0.63 nM.
  • High purity (≈98.3%) suitable for research assays.
  • Molecular weight 672.67 g·mol⁻¹.
  • White to off-white solid; available as DMSO solution concentrates.
  • Used to study fibrotic pathways in liver and lung models.

Catalog No. 50-002-15007 Supplier Medchemexpress LLC Supplier No. HY100445A10MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

αvβ1 integrin-IN-1 TFA (Compound C8) is a potent, selective small-molecule inhibitor of αvβ1 integrin for research use. It has an IC50 of 0.63 nM and demonstrates antifibrotic effects in mouse models of liver and lung fibrosis. Supplied as a white to off-white solid and as DMSO solutions, it is provided with high purity for biochemical and cellular assays.

  • Potent αvβ1 inhibition with IC50 0.63 nM.
  • High purity (≈98.3%) suitable for research assays.
  • Molecular weight 672.67 g·mol⁻¹.
  • White to off-white solid; available as DMSO solution concentrates.
  • Used to study fibrotic pathways in liver and lung models.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.